Contact
Please use this form to send email to PR contact of this press release:
Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of RuzurgiĀ® (amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination
TO: